title: MTHFR C677T homozygous as risk factor for complications after OLT for cryptogenic cirrhosis.
authors.forename: Linda
authors.initials: L
authors.lastname: Pasta
authors.forename: Ciro
authors.initials: C
authors.lastname: Marrone
authors.forename: Mario
authors.initials: M
authors.lastname: D'Amico
authors.forename: Roberto
authors.initials: R
authors.lastname: Verdone
authors.forename: Aroldo
authors.initials: A
authors.lastname: Rizzo
authors.forename: Piero
authors.initials: P
authors.lastname: Sammarco
authors.forename: Carmelo
authors.initials: C
authors.lastname: Fabiano
authors.forename: Marcello
authors.initials: M
authors.lastname: Niceta
authors.forename: Maria
authors.initials: M
authors.lastname: Caltagirone
authors.forename: Gennaro
authors.initials: G
authors.lastname: D'Amico
authors.forename: Luigi
authors.initials: L
authors.lastname: Pagliaro
mesh_terms: D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2) / Q000235:genetics*; D000328:Adult; D001706:Biopsy; D004247:DNA / Q000235:genetics; D005260:Female; D006720:Homozygote; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011183:Postoperative Complications; D012307:Risk Factors
chemical_list: D004247:DNA; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2)